Cypress Point Wealth Management, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cypress Point Wealth Management, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$370,000
+84.1%
8,522
+100.0%
0.13%
-7.7%
Q2 2021$201,000
-7.8%
4,2610.0%0.14%
-37.0%
Q1 2021$218,000
+91.2%
4,2610.0%0.23%
+31.2%
Q4 2020$114,0004,2610.17%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$40,100,00021.56%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$571,412,0002.71%
Nan Fung Group Holdings Ltd 210,563$5,416,0002.57%
Taikang Asset Management (Hong Kong) Co Ltd 533,332$13,717,0002.34%
Crawford Lake Capital Management, LLC 168,200$4,326,0001.80%
BOULDER HILL CAPITAL MANAGEMENT LP 126,900$3,264,0001.75%
Zebra Capital Management LLC 22,227$572,0001.31%
Alaska Permanent Fund Corp 2,300,000$59,156,0000.98%
CLARK ESTATES INC/NY 180,000$4,630,0000.73%
Temasek Holdings (Private) Ltd 5,602,553$144,097,6630.61%
View complete list of VIR BIOTECHNOLOGY INC shareholders